ProCE Banner Series

A Discussion of the Rapidly Evolving Landscape in Endometrial Cancer: Addressing Clinical Changes, Challenges, and Disparities

Live webinar with experts covering the evolving landscape in the management of endometrial cancers with novel treatments and combinations, from Clinical Care Options (CCO).

  AMA
Who Should Attend

This educational program is intended for medical oncologists, gynecologic oncologists, and other healthcare professionals who care for patients with endometrial cancer.

All Events

A Discussion of the Rapidly Evolving Landscape in Endometrial Cancer: Addressing Clinical Changes, Challenges, and Disparities

Past Events

April

11

2024

2:00 PM - 3:00 PM Central Time (CT)

Virtual

April

23

2024

11:00 AM - 12:00 PM Central Time (CT)

Virtual

Faculty

ProCE Banner Faculty
Ramez N. Eskander, MD

Clinical Professor of Gynecologic Oncology
Clinical Trials Office Director for Oncology at UC San Diego Health and Moores Cancer Center
Co-Director, UC San Diego Health International Patient Program
Fellowship Director, Gynecologic Oncology
Member of the GOG Foundation
Associate Clinical Trial Advisor, GOG Partners
San Diego, California

ProCE Banner Faculty
David Scott Miller, MD, FACOG, FACS

Medical Director of Gynecologic Oncology
Chair, Cancer Committee
Parkland Health & Hospital System
Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
Direct and Dallas Foundation Chair in Gynecologic Oncology
Professor of Obstetrics and Gynecology
University of Texas Southwestern Medical Center
Dallas, Texas

ProCE Banner Faculty
Shannon N. Westin, MD, MPH, FASCO

Professor
Medical Director, Gynecologic
Oncology Center
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Topics

Gynecologic cancers

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in the treatment of endometrial cancer. 

Target Audience
This educational program is intended for medical oncologists, gynecologic oncologists, and other healthcare professionals who care for patients with endometrial cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Explain the underlying molecular biology of endometrial cancer and the rationale for precision approaches to treatment
  • Order and interpret molecular testing to aid in optimal therapy selection for patients with endometrial cancer
  • Plan individualized treatment strategies for patients with newly diagnosed and recurrent or relapsed endometrial cancer that incorporate approved and novel therapies and combination strategies
  • Identify patients with endometrial cancer who are at high risk for poor outcomes because of racial/ethnic, socioeconomic, or other demographic features

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from GlaxoSmithKline.